Meeting
2019 Genitourinary Cancers Symposium
A genomic classifier shows improved prediction of oncologic outcomes in African-American men treated with radical prostatectomy.
Authors
Stephen J. Freedland
Cedars-Sinai Medical Center, Los Angeles, CA
Stephen J. Freedland , Marguerite Du Plessis , Jingbin Zhang , Lauren Howard , Amanda de Hoedt , Elai Davicioni
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 8)
DOI
10.1200/JCO.2019.37.7_suppl.8
Abstract #
8
Poster Bd #
A18
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Prospective randomized trial of genomic classifier impact on treatment decisions in patients at high risk of recurrence following radical prostatectomy (G-MINOR).
First Author: Todd Matthew Morgan
Poster
2023 ASCO Genitourinary Cancers Symposium
Evaluating p53 nuclear expression and prostate cancer progression in a predominantly African American cohort.
First Author: William Gesztes
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2019 Genitourinary Cancers Symposium
Percent genome alteration and outcomes after radical prostatectomy in African American men.
First Author: Farzana A Faisal